Trials / Terminated
TerminatedNCT02608411
TIvantinib as Maintenance Treatment in Extended Small-cell Lung Cancer (TIMES)
TIvantinib as Maintenance Treatment in Extended Small-cell Lung Cancer (TIMES). Phase II Clinical Trial, Single Arm, Two Stage
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 5 (actual)
- Sponsor
- Istituto Oncologico Veneto IRCCS · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to assess the role of MET inhibitors as maintenance treatment in adult patients with extensive stage small cell lung cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ARQ197 |
Timeline
- Start date
- 2016-02-19
- Primary completion
- 2017-02-21
- Completion
- 2017-02-21
- First posted
- 2015-11-18
- Last updated
- 2023-10-13
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT02608411. Inclusion in this directory is not an endorsement.